News

Big names in the fashion industry, such as the editorial director of British Vogue, Chioma Nnadi, has previously expressed ...
Diabetic weight loss medications are effective for people with schizophrenia without affecting psychotic symptoms, University ...
Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...
Share on Pinterest Ozempic, the active ingredient of which is semaglutide ... which included having an urgent medical visit or hospitalization from heart failure and death from cardiovascular ...
In real-world cohort, percentage weight reduction at 1 year was 3.6%, 6.8%, and 11.9% with early and late discontinuation and nondiscontinuation, respectively.
Weight loss treatment combining personalized semaglutide with intensive behavioral therapy (IBT) yields weight loss similar to that reported in confirmatory trials, with a lower dose of medication.
Given the evidence, the committee has recommended that the labels for Novo Nordisk’s Wegovy and Ozempic be updated to include ...
A new study has found a significant association between the use of GLP-1s such as Ozempic and Wegovy with a higher risk of developing a serious eye condition in patients with diabetes. Here are four t ...
Former FDA chief Dr. David Kessler says the new weight-loss drugs are a powerful tool to fight obesity. But they come with ...
The poster will feature Rakuten Medical's ongoing global Phase 3 clinical trial evaluating ASP-1929 photoimmunotherapy in combination with pembrolizumab (anti-PD-1) as a first-line therapy for ...